{"id":1047970,"title":"DSEN Abstract: Safety, effectiveness, and cost-effectiveness of long-acting versus intermediate-acting insulin for patients with type 1 diabetes: a systematic review and network meta-analysis - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-11","captureTimestamp":"2026-03-11T14:05:22.807000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/51394.html?wbdisable=true","snippet":"DSEN Abstract Safety, effectiveness, and cost-effectiveness of long-acting versus intermediate-acting insulin for patients with type 1 diabetes: a systematic review and network meta-analysis This research was funded by the Drug Safety and Effectiveness Network (DSEN) and…","rawSnapshotUrl":"/api/snapshots/raw/1047970","browseUrl":"https://replay.healtharchive.ca/job-8/20260311140522/https://cihr-irsc.gc.ca/e/51394.html?wbdisable=true#ha_snapshot=1047970","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}